BLUE JET HEALTHCARE LTD (BLUEJET) financials
BLUE JET HEALTHCARE LTD (BLUEJET) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]
- Market Cap: ₹9,855Cr.
- Current Price: ₹521
- Stock P/E: 42.0
- ROE: 19.4%
- ROCE: 26.1%
- Book Value: ₹78.4
- Dividend Yield: 0.23%
- 52W High / Low: ₹688/325
In Jun 2026, BLUE JET HEALTHCARE LTD (BLUEJET) reported sales ₹293 Cr and net profit ₹78 Cr.
Annual TTM: sales ₹886 Cr, net profit ₹235 Cr.
Shareholding: Promoters 73.15% (Sep 2026), FIIs 0.81% (Sep 2026), DIIs 7.48% (Sep 2026), Public 18.56% (Sep 2026), No. of Shareholders 79,390% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 208 | 318 | 340 | 355 | 165 | 192 | 235 | 293 |
| Expenses | 139 | 194 | 200 | 234 | 111 | 146 | 163 | 195 |
| Operating Profit | 69 | 124 | 140 | 121 | 55 | 47 | 71 | 98 |
| OPM % | 33% | 39% | 41% | 34% | 33% | 24% | 30% | 33% |
| Other Income | 12 | 13 | 12 | 8 | 24 | 13 | 23 | 15 |
| Interest | 0 | 0 | 0 | 1 | 5 | 0 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
| Profit before tax | 77 | 132 | 147 | 123 | 69 | 54 | 87 | 106 |
| Tax % | 24% | 25% | 25% | 26% | 24% | 25% | 26% | 26% |
| Net Profit | 58 | 99 | 110 | 91 | 52 | 40 | 64 | 78 |
| EPS in Rs | 3.36 | 5.71 | 6.35 | 5.26 | 3.01 | 2.32 | 3.71 | 4.51 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 538 | 499 | 683 | 721 | 712 | 1,030 | 947 | 886 |
| Expenses | 325 | 292 | 434 | 502 | 481 | 652 | 653 | 614 |
| Operating Profit | 214 | 207 | 249 | 219 | 231 | 378 | 294 | 271 |
| OPM % | 40% | 41% | 36% | 30% | 32% | 37% | 31% | 31% |
| Other Income | 6 | 9 | 19 | 24 | 18 | 46 | 69 | 76 |
| Interest | 7 | 5 | 3 | 1 | 0 | 0 | 6 | 6 |
| Depreciation | 18 | 20 | 22 | 25 | 28 | 18 | 24 | 25 |
| Profit before tax | 194 | 190 | 243 | 217 | 220 | 406 | 333 | 316 |
| Tax % | 25% | 26% | 25% | 26% | 26% | 25% | 25% | — |
| Net Profit | 145 | 142 | 182 | 160 | 164 | 305 | 248 | 235 |
| EPS in Rs | 137.82 | 8.16 | 10.47 | 9.23 | 9.44 | 17.59 | 14.29 | 13.55 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 11% | 7% | 8% | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.60 | 10 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 198 | 330 | 487 | 647 | 811 | 1,098 | 1,325 |
| Borrowings | 74 | 52 | 19 | 5 | 3 | 21 | 44 |
| Other Liabilities | 92 | 142 | 173 | 176 | 211 | 263 | 238 |
| Total Liabilities | 364 | 534 | 713 | 862 | 1,059 | 1,418 | 1,641 |
| Fixed Assets | 107 | 139 | 156 | 151 | 172 | 300 | 316 |
| CWIP | 2 | 3 | 3 | 30 | 147 | 89 | 301 |
| Investments | 26 | 37 | 94 | 189 | 250 | 187 | 252 |
| Other Assets | 229 | 355 | 460 | 491 | 489 | 841 | 771 |
| Total Assets | 364 | 534 | 713 | 862 | 1,059 | 1,418 | 1,641 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 122 | 137 | 146 | 142 | 241 | 46 | 334 |
| Cash from Investing Activity | -45 | -61 | -76 | -147 | -264 | -35 | -276 |
| Cash from Financing Activity | -72 | -21 | -56 | -4 | -2 | -19 | -31 |
| Net Cash Flow | 5 | 55 | 14 | -10 | -24 | -8 | 28 |
| Free Cash Flow | 106 | 85 | 125 | 83 | 68 | -34 | 115 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 80% | 66% | 70% | 92% | 109% | 36% | 151% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 86.00% | 86.00% | 86.00% | 79.81% | 79.81% | 79.81% | 79.81% | 73.15% |
| FIIs | 1.10% | 2.28% | 1.97% | 1.83% | 1.14% | 0.89% | 0.40% | 0.81% |
| DIIs | 2.02% | 1.33% | 0.95% | 3.63% | 4.65% | 4.51% | 4.65% | 7.48% |
| Public | 10.87% | 10.38% | 11.08% | 14.74% | 14.41% | 14.80% | 15.14% | 18.56% |
| No. of Shareholders | 43,003 | 54,581 | 70,772 | 80,117 | 80,187 | 79,199 | 78,917 | 79,390 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 105 | 121 | 121 | 91 | 124 | 131 |
| Inventory Days | 120 | 253 | 133 | 137 | 151 | 209 | 157 |
| Days Payable | 90 | 128 | 72 | 58 | 35 | 70 | 48 |
| Cash Conversion Cycle | 110 | 231 | 183 | 199 | 206 | 262 | 240 |
| Working Capital Days | 55 | 89 | 103 | 120 | 92 | 157 | 136 |
| ROCE % | — | 58% | 53% | 35% | 30% | 40% | 26% |
Blue Jet Healthcare Ltd
₹9,855Cr.
₹521
₹688/325
42.0
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of BLUE JET HEALTHCARE LTD (BLUEJET)?
The reported market capitalisation for BLUE JET HEALTHCARE LTD (BLUEJET) is ₹9,855Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of BLUEJET?
The current price shown for BLUE JET HEALTHCARE LTD (BLUEJET) on Fincrux is ₹521 with a 52-week high/low of ₹688/325.
What is the P/E ratio of BLUE JET HEALTHCARE LTD (BLUEJET)?
The stock P/E for BLUE JET HEALTHCARE LTD (BLUEJET) is 42.0 on Fincrux, with ROE at 19.4% and ROCE at 26.1%.
What were BLUEJET latest quarterly results?
For Jun 2026, BLUE JET HEALTHCARE LTD (BLUEJET) reported sales ₹293 Cr and net profit ₹78 Cr (figures in ₹ crore unless noted).
What are BLUEJET annual sales and net profit?
For TTM, BLUE JET HEALTHCARE LTD (BLUEJET) shows sales of ₹886 Cr and net profit of ₹235 Cr on the Fincrux profit & loss statement.
Who owns BLUE JET HEALTHCARE LTD (BLUEJET)?
Latest shareholding for BLUE JET HEALTHCARE LTD (BLUEJET) on Fincrux: Promoters 73.15% (Sep 2026), FIIs 0.81% (Sep 2026), DIIs 7.48% (Sep 2026), Public 18.56% (Sep 2026), No. of Shareholders 79,390% (Sep 2026).
Where can I find BLUE JET HEALTHCARE LTD (BLUEJET) financials?
BLUE JET HEALTHCARE LTD (BLUEJET) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show BLUEJET balance sheet and cash flow?
Yes. The BLUE JET HEALTHCARE LTD (BLUEJET) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.